The likelihood of contracting oral cancer increases by 325% if a patient is diagnosed with cannabis use disorder, according ...

The alarming trend of rising health issues among children is now being scrutinized more closely than ever, and it's time for parents and caregivers to take action. Recent research has revealed that ...

Rather, it was the Danish pharmaceutical company's No. 1 rival. Appreciative investors bid up Novo Nordisk's stock in a ...

The QRISK3 assessment is designed for the general population, but it appears to also have utility in patients with essential thrombosis and polycythemia vera.

A new "heart age" calculator presents a person's heart disease risk as a relative age, rather than a percentage. That could ...

(HealthDay News) — A considerable proportion of adolescents and young adults eligible for glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are uninsured, and many young adults do not have a ...

Experts understand the size of one body part can indicate whether you're likely to experience issues when you're older, including diseases like Sarcopenia.

Q2 2025 Earnings Call Transcript August 6, 2025 LivaNova PLC beats earnings expectations. Reported EPS is $1.05, expectations were $0.84. Operator: Good day, ladies and gentlemen, and welcome to the ...

Glucagon-like peptide-1 (GLP-1) is a natural, gut-derived hormone that is released after we eat. It has beneficial effects ...

Britain's pharmacy regulator warned it had been forced to step in, to 'investigate concerns' that prescription drugs had been ...

In an 18-month clinical trial of the experimental GLP-1 pill orforglipron, about 60 percent of people lost at least 10 ...